News
In a series of recent legal challenges initiated by the pharmaceutical industry against the US Department of Health and Human Services Office of ...
Zacks Research has upped the financial bar for Vertex Pharmaceuticals, boosting its 2026 earnings forecast from $16.18 to $16 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback